TIPS Combined With Lenvatinib and PD-1 Inhibitor for Advanced HCC With Main Trunk PVTT

NCT06622031 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma
Portal Vein Tumor Thrombus
Systemic Therapy

Interventions

PROCEDURE: Transjugular intrahepatic portosystemic shunt
DRUG: Lenvatinib
DRUG: PD-1 inhibitor

Sponsor

Sun Yat-sen University

Collaborators

[object Object]